Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Ocular Complications 

Ocular Complications
Chapter:
Ocular Complications
Author(s):

James P. Dunn

DOI:
10.1093/med/9780190493097.003.0040
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 08 December 2019

Before the era of antiretroviral therapy (ART), cytomegalovirus (CMV) retinitis was the most common ocular opportunistic infection in patients with AIDS, occurring in up to 30% of patients. The incidence of CMV retinitis, its natural history, and the indications for and response to therapy depend in part on whether at-risk patients are taking ART. Symptoms of CMV retinitis are nonspecific and include floaters, light flashes, peripheral visual field loss, and blurred central vision. Patients taking ART, especially those with immune recovery, are at lower risk of CMV retinitis than are patients who remain profoundly immunosuppressed; thus, patients taking ART do not need to be screened as often.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.